VINHOMES GOLDEN CITY CHÍNH THỨC CÔNG BỐ GIÁ BÁN CHỈ TỪ 4,9 TỶ ĐỒNG, KHIẾN NĐT MIỀN BẮC VỘI CHỐT ĐƠN

Vinhomes Golden City tại Dương Kinh, Hải Phòng vừa chính thức công bố giá và chính sách bán hàng cho Phân khu Ánh Sao, và dân tình đang xôn xao khi giá chỉ từ 4,9 tỷ/căn thấp tầng, mức giá “khó tin” cho một dự án Vinhomes tại miền Bắc.

Ngoài ra, chính sách thanh toán siêu linh hoạt, giãn tới 810 ngày, hỗ trợ tối đa cho nhà đầu tư.

Ngay sau khi công bố, mạng xã hội chấn động khi booking giữ chỗ đã xấp xỉ 3.000, trong khi lượng mở bán chỉ vài trăm căn. Chưa mở bán đã gây sốt, vừa chốt giá đã cháy hàng.

Dự án toạ lạc tại trung tâm Dương Kinh, Hải Phòng, khu vực đang hot lên nhờ hạ tầng nghìn tỷ như Cầu Rào 3, Vành đai 2, đường sắt liên vận quốc tế và sáp nhập mở ra cơ hội tăng giá mạnh mẽ.

Vinhomes Golden City không chỉ là nơi an cư mà còn là điểm rót vốn vàng cho giới đầu tư săn đón làn sóng bất động sản mới đầy tiềm năng.

In just 110 days, China has achieved a remarkable feat of engineering — completing the world’s widest underwater roadway, the Jinan Huanggang Road Tunnel beneath the mighty Yellow River. Measuring 55.8 feet wide and stretching over 2 miles, the tunnel was excavated with "Shanhe", the largest tunnel boring machine ever used in the region, capable of cutting through the riverbed at a rate of 59 feet per day.

What makes this project even more impressive is its structural precision: it required over 500 reinforced pipe rings to stabilize the underwater passage. Once operational in late 2025, this six-lane tunnel will serve as a vital link between the northern and southern districts of Jinan, reducing congestion, boosting logistics, and symbolizing China's commitment to next-generation infrastructure.

This isn't just a tunnel — it’s a milestone in rapid urban connectivity built at an unprecedented pace.

#EngineeringMarvel #ChinaInfrastructure #TunnelTechnology #SmartCities #CivilEngineering

Cochinita Pibil – Yucatán-Style Slow-Roasted Pork

A Mayan heritage dish: pork marinated in achiote and citrus, wrapped in banana leaves and slow-roasted until juicy and vibrant.

Ingredients (Serves 6):
* 1.5kg pork shoulder, cut into large chunks
* 3 tbsp achiote paste
* 1/2 cup orange juice
* 1/4 cup lime juice
* 5 garlic cloves
* 1 tbsp vinegar
* 1 tsp cumin
* Salt
* Banana leaves or foil

Instructions:
1. Blend achiote paste with juices, garlic, vinegar, and cumin.
2. Marinate pork overnight.
3. Wrap in banana leaves or foil, place in tray.
4. Roast at 160°C (320°F) for 3.5 hours.
5. Shred and serve with tortillas, rice, and pickled onions.

Mexican Tip:
Add sliced habanero to the pickled onions for an authentic spicy kick, or top with roasted pineapple chunks for a sweet contrast.

GARGANTUAN JALAPEÑO POPPER DEEP DISH

Ingredients:
2 cups pizza dough
1 ½ cups diced jalapeños (seeds removed for less heat)
1 cup cream cheese, softened
1 cup shredded cheddar
½ cup crispy bacon bits
½ cup diced onions
½ cup ranch or sour cream drizzle
Optional: chopped chives or cilantro

Instructions:
1⃣ Press dough into deep dish pan.
2⃣ Mix jalapeños, cream cheese, cheddar, bacon, and onions.
3⃣ Spread mixture evenly over dough.
4⃣ Bake until crust is golden and cheese bubbly.
5⃣ Drizzle ranch or sour cream, garnish with herbs, serve spicy & creamy!

Prep: 20 min | Cook: 30 min | Total: 50 min | Serves: 6

In June 2025, the U.S. Food and Drug Administration (FDA) officially approved Yeztugo (lenacapavir) as the world’s first twice-yearly injection for HIV prevention (PrEP).

Developed by Gilead Sciences, this landmark drug offers long-term protection from HIV with just two subcutaneous shots per year.

The approval is based on extensive clinical trials under the PURPOSE 1 and 2 studies, which showed near-perfect efficacy—zero new infections in cisgender women and only two infections across a broader population of over 2,000 individuals.

This brings its protective rate to approximately 99.9%, making it the most effective and long-acting HIV prevention method available today.

Lenacapavir works by targeting the HIV capsid, a protein shell that encases the virus’s genetic material.

By inhibiting this capsid, the drug prevents HIV from replicating inside human cells.

Unlike daily oral PrEP options like Truvada or Descovy, Yeztugo is designed to overcome common adherence issues by requiring just one injection every six months. This simplifies prevention for at-risk

populations, especially those who struggle with daily medication routines.

While the approval is being hailed as a major victory in the global fight against HIV, access and affordability remain concerns.

The U.S. list price for a year’s supply is expected to be around $28,000, though Gilead has committed to providing generics to 120 low-income countries and producing up to 10 million doses by 2026.

Global health experts see this breakthrough as a turning point that could drastically reduce new HIV infections—if distribution is equitable and timely.

In summary, Yeztugo's approval represents a critical milestone in HIV prevention science, combining exceptional efficacy, convenience, and innovation.

It has the potential to reshape the future of HIV prevention—especially if healthcare systems can ensure widespread access to those most in need.